SEC
SlamSEC
SearchBrowseEarnings

Sagimet Biosciences Inc.

Nasdaq:SGMT
Pharmaceutical Preparations·SAN MATEO, CA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(219 total)

TypeDateAccessionPeriodSize
S-8
Mar 11, 2026
0001104659-26-026154FORM S-8
—
207.6 KB
S-8
Mar 11, 2026
0001104659-26-026152FORM S-8
—
206.8 KB
8-K
Mar 11, 2026
0001104659-26-026146FORM 8-K
Mar 11, 2026
18.9 MB
10-K
Mar 11, 2026
0001104659-26-02614010-K
Dec 31, 2025
11.3 MB
4
Feb 20, 2026
0001104659-26-018196OWNERSHIP DOCUMENT
Feb 19, 2026
7.4 KB
4
Feb 20, 2026
0001104659-26-018194OWNERSHIP DOCUMENT
Feb 19, 2026
7.4 KB
4
Feb 20, 2026
0001104659-26-018193OWNERSHIP DOCUMENT
Feb 19, 2026
7.4 KB
4
Feb 20, 2026
0001104659-26-018191OWNERSHIP DOCUMENT
Feb 19, 2026
7.4 KB
4
Feb 12, 2026
0001104659-26-014283OWNERSHIP DOCUMENT
Feb 10, 2026
4.9 KB
4
Feb 12, 2026
0001104659-26-014277OWNERSHIP DOCUMENT
Feb 10, 2026
4.9 KB
4
Feb 12, 2026
0001104659-26-014272OWNERSHIP DOCUMENT
Feb 10, 2026
4.9 KB
4
Feb 12, 2026
0001104659-26-014266OWNERSHIP DOCUMENT
Feb 10, 2026
4.9 KB
8-K
Feb 2, 2026
0001104659-26-008925FORM 8-K
Feb 2, 2026
10.7 MB
SCHEDULE 13G/A
Dec 18, 2025
0001104659-25-122583
—
8.4 KB
8-K
Dec 18, 2025
0001104659-25-122272FORM 8-K
Dec 18, 2025
11.7 MB
8-K
Dec 17, 2025
0001104659-25-121819FORM 8-K
Dec 17, 2025
257.0 KB
4
Nov 21, 2025
0001104659-25-115071OWNERSHIP DOCUMENT
Nov 20, 2025
5.3 KB
144
Nov 20, 2025
0001950047-25-009150
—
4.8 KB
SCHEDULE 13G/A
Nov 14, 2025
0000902664-25-005028
—
8.7 KB
8-K
Nov 13, 2025
0001104659-25-110852FORM 8-K
Nov 13, 2025
11.8 MB
10-Q
Nov 13, 2025
0001104659-25-11084610-Q
Sep 30, 2025
6.4 MB
4
Nov 6, 2025
0001104659-25-107806OWNERSHIP DOCUMENT
Nov 4, 2025
7.6 KB
8-K
Oct 23, 2025
0001104659-25-101819FORM 8-K
Oct 23, 2025
9.3 MB
8-K
Aug 22, 2025
0001104659-25-081630FORM 8-K
Aug 18, 2025
198.9 KB
SCHEDULE 13G/A
Aug 14, 2025
0000902664-25-003696
—
10.9 KB
25 filings shown
CEO
Happel David
CFO
Chauche Thierry